adalimumab biosimilar
/ Stada, mAbxience
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
December 07, 2022
"$ALVO Alvotech and STADA Broaden Access to Hukyndra® adalimumab biosimilar in Europe https://t.co/Dxl6pnreVy"
(,@stock_titan)
October 08, 2016
Stada: Capital Markets Day 2016
(Stada)
- Anticipated launch in inflammatory disease in 2019
Anticipated biosimilar launch • Biosimilar
1 to 2
Of
2
Go to page
1